Wynn Capital, LLC Abbott Laboratories Transaction History
Wynn Capital, LLC
- $135 Billion
- Q2 2024
A detailed history of Wynn Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wynn Capital, LLC holds 3,427 shares of ABT stock, worth $398,902. This represents 0.26% of its overall portfolio holdings.
Number of Shares
3,427
Previous 3,427
-0.0%
Holding current value
$398,902
Previous $390 Million
8.58%
% of portfolio
0.26%
Previous 0.3%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,133Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$19.4 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.3 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.66 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.36 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.66 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $204B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...